Amneal Pharmaceuticals, Inc. (FRA:2DT)

Amneal Pharmaceuticals Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 4, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	3,291	2,370	1,683	282	629	552
Market Cap Growth	33.27%	40.80%	496.83%	-55.17%	14.07%	-4.24%
Enterprise Value	5,483	4,908	4,011	2,796	2,965	2,837
Last Close Price	10.00	7.35	5.45	1.83	4.26	3.61
PE Ratio	654.53	-	-	-	67.35	7.41
PS Ratio	1.32	0.88	0.78	0.14	0.34	0.34
PB Ratio	-91.56	-55.10	30.35	1.44	1.86	1.89
P/FCF Ratio	15.47	10.45	6.23	18.49	3.75	2.13
P/OCF Ratio	11.78	8.32	5.38	4.63	2.96	1.78
EV/Sales Ratio	2.17	1.82	1.85	1.35	1.61	1.74
EV/EBITDA Ratio	9.90	8.69	8.85	6.79	7.49	9.11
EV/EBIT Ratio	16.64	14.59	16.34	14.94	15.57	23.83
EV/FCF Ratio	25.77	21.64	14.84	183.29	17.67	10.94
Debt / Equity Ratio	-63.68	-58.22	44.87	13.62	7.52	8.41
Debt / EBITDA Ratio	4.17	4.28	5.26	6.15	6.15	7.36
Debt / FCF Ratio	10.76	11.05	9.21	174.50	15.13	9.46
Asset Turnover	0.83	0.80	0.66	0.57	0.53	0.52
Inventory Turnover	3.04	2.98	2.75	2.79	2.67	3.08
Quick Ratio	1.31	0.82	0.87	1.10	1.39	1.49
Current Ratio	2.13	1.41	1.63	1.88	2.25	2.29
Return on Equity (ROE)	-	-881.26%	-36.06%	-85.96%	5.45%	19.50%
Return on Assets (ROA)	6.79%	6.24%	4.67%	3.23%	3.41%	2.37%
Return on Capital (ROIC)	9.12%	8.12%	5.78%	3.95%	4.08%	2.81%
Return on Capital Employed (ROCE)	14.00%	14.70%	10.30%	6.60%	6.60%	4.40%
Earnings Yield	0.15%	-4.76%	-4.51%	-43.12%	1.49%	13.50%
FCF Yield	6.46%	9.57%	16.06%	5.41%	26.68%	47.01%
Buyback Yield / Dilution	-9.44%	-75.42%	-16.69%	0.58%	-1.95%	-12.72%
Total Shareholder Return	-9.44%	-75.42%	-16.69%	0.58%	-1.95%	-12.72%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.